+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "HIV Vaccine"

From
The 2022 World Market for Vaccines - Product Thumbnail Image

The 2022 World Market for Vaccines

  • Report
  • October 2022
  • 194 Pages
  • Global
From
From
Vaccines Markets in China - Product Thumbnail Image

Vaccines Markets in China

  • Report
  • July 2024
  • 326 Pages
  • China
From
Vaccines Industry Forecasts - China Focus - Product Thumbnail Image

Vaccines Industry Forecasts - China Focus

  • Report
  • July 2024
  • 187 Pages
  • China
From
  • 7 Results (Page 1 of 1)
Loading Indicator

The HIV Vaccine market is a subset of the larger Vaccine market, which is focused on the development of vaccines to prevent HIV infection. HIV vaccines are designed to induce an immune response that will protect individuals from HIV infection. Vaccines are developed through a variety of approaches, including the use of live attenuated viruses, recombinant proteins, and DNA-based vaccines. The HIV Vaccine market is highly competitive, with many companies and research institutions working to develop effective vaccines. Companies in the market include GlaxoSmithKline, Merck, Sanofi Pasteur, Johnson & Johnson, and Pfizer. Additionally, many non-profit organizations, such as the International AIDS Vaccine Initiative, are actively involved in the development of HIV vaccines. Show Less Read more